Overview

Study to Evaluate the Efficacy and Safety of HIP2101 in Patients With Acute or Chronic Gastritis

Status:
Recruiting
Trial end date:
2021-12-31
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to investigate the safety and clinical efficacy of HIP2101 in patients with acute or chronic gastritis.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Hanmi Pharmaceutical Company Limited
Criteria
Inclusion Criteria:

- 19≤ age ≤ 75

- Have been diagnosed as acute or chronic gastritis with at least 1 erosion by endoscopy
within 7 days before enrollment.

- Patients understood the consents and purpose of this trial and signed consent form

Exclusion Criteria:

- Patients who cannot perform endoscopy

- Active gastric or duodenal ulcer

- Reflux esophagitis, barrett's esophagus, gastric or esophageal varix

- Zollinger-Ellison syndrome, pyloric obstruction, and esophageal stricture,
Inflammatory Bowel Diease, acute pancreatitis

- History of gastrointestinal surgery

- History of malignancy tumor, especially in the upper gastrointestinal tract

- Severe liver disorder(at screening day, AST or ALT level exceeds 3 times more than
normal upper range)

- Severe renal disorder(at screening day, MDRD eGFP ≤ 30 mL/min/1.73m2) or chronic renal
disease

- Bleeding disorder

- Patients who have taken drugs containing following list within 2 weeks before
endoscopy : H2-receptor antagonists, Proton pump inhibitors, P-CABs, gastrin
inhibitors, antacids, gastric mucosal protectants, anticholinergics

- Patients who have taken anticoagulants within a week before endoscopy

- Patients who have taken drugs containing following list after endoscopy : GI tract
regulators, salicylates, steroids, , NSAIDs, bisphosphonates, selective serotonin
reuptake inhibitors, iron supplements, oriental herbal medicines

- History of allergic reaction to the medications used in this study

- Use of other investigational drugs within 30 days prior to the study

- History of alcohol or drug abuse

- Positive to pregnancy test, nursing mother, intention on pregnancy

- Considered by investigator as not appropriate to participate in the clinical study
with other reason